Molecular approaches to disease control

Poultry Science

Volumn 82, Issue 6, 2003, Pages 870-875

  Babiuk, L A ^a   Gomis, S ^a   Hecker, R ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b QIAGEN GMBH   (Germany)

Author keywords

Adjuvant; Cellulite; CpG motif; Immunotherapy; Innate immunity

Indexed keywords

ANIMALIA; ESCHERICHIA COLI; GALLUS GALLUS; VERTEBRATA;

ANIMAL; ANIMAL DISEASE; BIRD DISEASE; CELLULAR IMMUNITY; CELLULITIS; CPG ISLAND; DISEASE MODEL; ENTEROBACTER INFECTION; ESCHERICHIA COLI; GENETICS; IMMUNOTHERAPY; PATHOGENICITY; POULTRY; REVIEW; T LYMPHOCYTE;

ANIMALS; CELLULITIS; CPG ISLANDS; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; IMMUNITY, CELLULAR; IMMUNOTHERAPY; POULTRY; POULTRY DISEASES; T-LYMPHOCYTES;

EID: 0043209768     PISSN: 00325791     EISSN: None     Source Type: Journal    
DOI: 10.1093/ps/82.6.870     Document Type: Conference Paper

References (30)

1. Aderem, A. R., and R. J. Ulevitch. 2000. Toll-like receptors in the induction of the innate immune response. Nature 406:782-787.
2. Cheville, N. F., and L. H. Arp. 1978. Comparative pathologic findings of Escherichia coli infections in birds. J. Am. Vet. Med. Assoc. 173:584-587.
3. Chu, R. S., O. S. Targoni, A. M. Krieg, P. V. Lehmann, and C. V. Harding. 1997. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186:1623-1631.
4. Davis, H. L., I. I. Suparto, R. R. Weeratna, D. D. Iskandriati, S. S. Chamzah, A. A. Ma'ruf, C. C. Nente, D. D. Pawitri, A. M. Krieg, W. H. Smits, and D. D. Sajuthi, 2000. CpG DNA overcomes hypo-responsiveness to hepatitis B vaccine in orangutans. Vaccine 18:1920-1924.
5. Elkins, K. L., T. R. Rhinehart-Jones, S. Stibitz, J. S. Conover, and D. M. Klinman. 1999. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J. Immunol. 162:2291-2298.
6. Fearon, D. T., and R. M. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50-53.
7. Gagic, M., C. A. St. Hill, and J. M. Sharma. 1999. In ovo vaccination of specific pathogen-free chickens with vaccines containing multiple agents. Avian Dis. 43:293-301.
8. Gomis, S. M., T. Watts, C. Riddell, A. A. Potter, and B. J. Allan. 1997. Experimental reproduction of Escherichia coli cellulitis and septicemia in broiler chickens. Avian Dis. 41:234-240.
9. Hacker, H., R. M. Vabulas, O. Takeuchi, K. Hoshino, S. Akira, and H. Wagner. 2000. Immune cell activation by bacterial Cpg DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. J. Exp. Med. 192:595-600.
10. Hadden, J. W. 1993. Immunostimulants. Trends Pharmacol. Sci. 14:169-174.
11. Heath, A. W., and J. H. L. Playfair. 1992. Cytokines as immunological adjuvants. Vaccine 10:427-434.
12. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A toll-like receptor recognizes bacterial DNA. Nature 408:740-745.
13. Hughes, H. P. A., and L. A. Babiuk. 1992. The adjuvant potential of cytokines. Biotech. Therap. 3:101-117.
14. Klinman, D. M., J. Conover, and C. Coban. 1999a. Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection. Infect. Immun. 67:5658-5663.
15. Klinman, D. M., D. Verthelyi, F. Takeshita, and K. J. Ishii. 1999b. Immune recognition of foreign DNA: a cure for bioterrorism? Immunity 11:123-129.
16. Krieg, A. M., A. K. Yi, S. Matson, T. J. Waldschmidt, G. A. Bishop, R. Teasdale, G. A. Koretzky, and D. M. Klinman. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546-549.
17. Krieg, A. M., L. Love-Homan, A. K. Yi, and J. T. Harty. 1998a. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J. Immunol. 161:2428-2434.
18. Krieg, A. M., T. Wu, R. Weeratna, S. M. Efler, L. Love-Homan, L. Yang, A. K. Yi, D. Short, and H. L. Davis. 1998b. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc. Natl. Acad. Sci. USA 95:12631-12636.
19. Krieg, A. M., and H. L. Davis. 2001. Enhancing vaccines with immune stimulatory CpG DNA. Curr. Opinion in Mol. Ther. 3:15-24.
20. Lipford, G. B., M. Bauer, and C. Blank. 1997. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvants. Eur. J. Immunol. 27:2340-2344.
21. McCluskie, M. J., and H. L. Davis. 1998. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. J. Immunol. 161:4463-4466.
22. McCluskie, M. J., and H. L. Davis. 2000. Oral, intrarectal, and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants. Vaccine 19:413-422.
23. Medzhitov, R., and C. Janeway. 2000. The toll receptor family and microbial recognition. Trends Microbiol. 8:452-456.
24. Moldoveanu, Z., L. Love-Homan, W. Q. Huang, and A. M. Krieg. 1998. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine 16:1216-1224.
25. Morley, A. J., and D. K. Thomson. 1984. Swollen head syndrome in broiler chickens. Avian Dis. 28:238-243.
26. Oxenius, A., M. M. Martinic, H. Hengartner, and P. Klenerman. 1999. CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines. J. Virol. 73:4120-4126.
27. Randall, C. J., P. A. Meakins, M. P. Harris, and D. J. Watt. 1984. A new skin disease in broilers? Vet. Rec. 114:246.
28. Tokunaga, T., H. Yamamoto, S. Shimada, H. Abe, T. Fukuda, Y. Fujisawa, Y. Furutani, O. Yano, T. Kataoka, and T. Sudo. 1984. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J. Natl. Cancer Inst. 72:955-962.
29. Vogels, M. T., and J. W. van der Meer. 1992. Use of immune modulators in nonspecific therapy of bacterial infections. Antimicrob. Agents Chemother. 36:1-5.
30. Zimmermann, S., O. Egeter, S. Hausmann, G. B. Lipford, M. Rocken, H. Wagner, and K. Heeg. 1998. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J. Immunol. 160:3627-3630.